MET and cancer: Mutations in Tg46 tumors impinged on cancer driver genes mostly related to phosphoinositide 3-kinases (PI3K)-Akt signaling (e.g., c-Met) and DNA repair (e.g., Brca1) pathways (Fig. 4C, D and Supplementary Fig. S2B).